US Smart E-cigarette Market to Reach $26.6 Billion by 2027

Mar.14.2023

The US smart e-cigarette market will reach $2.66 billion by 2027 with a 39.3% compound annual growth rate.

According to data from think tank organization Astute Analytica, the smart electronic cigarette market in the United States (both with and without displays) was valued at $364.7 million in 2021 and is expected to reach $2.664.9 billion by the end of 2027.

During the forecast period of 2022-2027, the compound annual growth rate of this market is projected to be 39.3%. In terms of quantity, the US smart e-cigarette market is expected to have a compound annual growth rate of 34.6% between 2022-2027.

According to a study by Astute Analytica, electronic cigarettes without screens currently dominate the smart electronic cigarette market in the United States with a 2021 market share of 86.2%. It is projected to grow at a compound annual growth rate of 34.3% during the forecast period.

However, electronic cigarettes with screens are expected to grow at a compound annual growth rate of 56%. Smart electronic cigarettes with screens display battery status and ingredient levels, which helps consumers predict usage time and thus accelerate overall growth in the near future.

Reference(s):

The smart e-cigarette market in the United States is projected to grow significantly by 2027. The industry dynamic is divided into two types: those with screens and those without screens, as well as online and offline distribution channels. This report provides a market size estimate and offers insights into opportunities and forecasts for the industry.

#Europe #Legislation #Open system e-cigarettes #Spain #E-cigarette #E-cigarettes and Tobacco #E-cigarette Market #Smart e-cigarettes

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Russia’s Vape Market Squeezed by Excise Hikes and Criminal Marking Rules

According to Business FM, Russia’s vape and e-liquid supply has tightened since mid-Aug; by early Oct top liquids had largely disappeared and prices rose ~50% vs early summer. Shops cite a two-year excise hike to RUB 44/mL and, from Aug, criminal liability for unmarked goods (large-scale from RUB 100k), prompting withdrawals. Some chains report compliant substitutes. A bill would let regions ban vape sales.

Oct.30 by 2FIRSTS.ai

Polish Government Plans Ban on Flavoured Nicotine Pouches and Disposable E-Cigarettes

Poland’s government is preparing to amend the Act on Protection of Health from the Consequences of Tobacco Use to ban the sale of flavoured nicotine pouches and disposable e-cigarettes. The Health Ministry says the goal is to protect youth from nicotine addiction, citing World Health Organization data on the risks of such products. However, industry representatives and legal experts argue the proposal is abrupt and could expand the illicit market.

Dec.05 by 2FIRSTS.ai

Morocco Aligns Cigarette Pricing Structure with New 2026 Tax Adjustment

Morocco will raise retail cigarette prices by 1–2 dirhams (≈ US$ 0.10–0.20) per pack starting January 1, 2026, as part of the final phase of its tobacco tax reform. The adjustment mainly affects value-category cigarette brands; premiums remain largely unchanged.

Dec.01

Philippine FDA Requires Licenses for Vape Products with Medical Claims

The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.

Dec.22 by 2FIRSTS.ai